Media Summary: Cancer is often seen by the immune system—just not attacked. In classical Hodgkin lymphoma, tumor cells exploit PD-1 signaling ... One American will die of melanoma every hour. Dr. Jeffrey Weber, director of the Donald A. Adam Comprehensive Melanoma ... A new immunotherapy at the Roper St. Francis Cancer Center is giving new hope to some patients with lung cancer. Join Dr. Mark ...

From Silence To Strike Opdivo - Detailed Analysis & Overview

Cancer is often seen by the immune system—just not attacked. In classical Hodgkin lymphoma, tumor cells exploit PD-1 signaling ... One American will die of melanoma every hour. Dr. Jeffrey Weber, director of the Donald A. Adam Comprehensive Melanoma ... A new immunotherapy at the Roper St. Francis Cancer Center is giving new hope to some patients with lung cancer. Join Dr. Mark ... Learn about a clinical trial that may help answer questions about the role of immunotherapy in combination with chemotherapy in ... Barry Hawes was the first person in New Zealand to receive the immunotheraphy drug 3 things to know about diarrhea when taking nivolumab (opdivo) for the tratmentnt of lung cancer.

Laura Chow, MD, Associate Professor, University of Washington School of Medicine, interprets the overall survival benefit with ... Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, provides a clinical study update on the use of ...

Photo Gallery

From Silence to Strike: Opdivo and Chemotherapy Move to the Frontline
How does Opdivo (Nivolumab) Work?
How Opdivo Cancer Treatment Works (Update)
Opdivo (nivolumab) the Immunotherapy Cancer Treatment
FDA approves OPDIVO® (nivolumab) in the United States
OPDIVO for Small Cell Lung Cancer
Lung Cancer Clinical Trial: Chemotherapy with or without Opdivo
Opdivo (nivolumab): Uses, How It Works, and Common Side Effects
Man's tumour shrinks significantly following Opdivo
3 things to know about diarrhea when taking nivolumab (opdivo) for the tratmentnt of lung cancer.
Laura Chow, MD interprets the overall survival benefit with Opdivo in the CheckMate-141 study
Opdivo failed in NSCLC
View Detailed Profile
From Silence to Strike: Opdivo and Chemotherapy Move to the Frontline

From Silence to Strike: Opdivo and Chemotherapy Move to the Frontline

Cancer is often seen by the immune system—just not attacked. In classical Hodgkin lymphoma, tumor cells exploit PD-1 signaling ...

How does Opdivo (Nivolumab) Work?

How does Opdivo (Nivolumab) Work?

Opdivo

How Opdivo Cancer Treatment Works (Update)

How Opdivo Cancer Treatment Works (Update)

Opdivo

Opdivo (nivolumab) the Immunotherapy Cancer Treatment

Opdivo (nivolumab) the Immunotherapy Cancer Treatment

Opdivo

FDA approves OPDIVO® (nivolumab) in the United States

FDA approves OPDIVO® (nivolumab) in the United States

One American will die of melanoma every hour. Dr. Jeffrey Weber, director of the Donald A. Adam Comprehensive Melanoma ...

OPDIVO for Small Cell Lung Cancer

OPDIVO for Small Cell Lung Cancer

A new immunotherapy at the Roper St. Francis Cancer Center is giving new hope to some patients with lung cancer. Join Dr. Mark ...

Lung Cancer Clinical Trial: Chemotherapy with or without Opdivo

Lung Cancer Clinical Trial: Chemotherapy with or without Opdivo

Learn about a clinical trial that may help answer questions about the role of immunotherapy in combination with chemotherapy in ...

Opdivo (nivolumab): Uses, How It Works, and Common Side Effects

Opdivo (nivolumab): Uses, How It Works, and Common Side Effects

Opdivo

Man's tumour shrinks significantly following Opdivo

Man's tumour shrinks significantly following Opdivo

Barry Hawes was the first person in New Zealand to receive the immunotheraphy drug

3 things to know about diarrhea when taking nivolumab (opdivo) for the tratmentnt of lung cancer.

3 things to know about diarrhea when taking nivolumab (opdivo) for the tratmentnt of lung cancer.

3 things to know about diarrhea when taking nivolumab (opdivo) for the tratmentnt of lung cancer.

Laura Chow, MD interprets the overall survival benefit with Opdivo in the CheckMate-141 study

Laura Chow, MD interprets the overall survival benefit with Opdivo in the CheckMate-141 study

Laura Chow, MD, Associate Professor, University of Washington School of Medicine, interprets the overall survival benefit with ...

Opdivo failed in NSCLC

Opdivo failed in NSCLC

Opdivo failed in NSCLC

Robert Filgin MD provides an update on nivolumab (Opdivo) in RCC

Robert Filgin MD provides an update on nivolumab (Opdivo) in RCC

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, provides a clinical study update on the use of ...